361 Capital’s Repligen RGEN Stock Holding History

361 Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$760K	Sell	6,152 -955	-13%	-$112K	0.36%	130
2020 Q1	$686K	Sell	7,107 -6,928	-49%	-$669K	0.31%	163
2019 Q4	$1.3M	Sell	14,035 -15,552	-53%	-$1.31M	0.36%	120
2019 Q3	$2.27M	Sell	29,587 -9,206	-24%	-$805K	0.42%	132
2019 Q2	$3.33M	Buy	+38,793	New	+$2.64M	0.59%	15
2018 Q4	–	Sell	-34,992	Closed	-$1.94M	–	393
2018 Q3	$1.94M	Buy	+34,992	New	+$1.8M	0.42%	67
2017 Q2	–	Sell	-5,730	Closed	-$202K	–	210
2017 Q1	$202K	Buy	+5,730	New	+$181K	0.04%	146

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

361 Capital's RGEN Position: Q2 2020 in Review

361 Capital reduced its Repligen (RGEN) stake by 13% in Q2 2020, selling an estimated $112K and leaving 6,152 shares worth $760K. The position accounts for 0.36% of the portfolio, ranked #130.

361 Capital first reported a position in RGEN in Q1 2017 and has held it in 7 quarters since. The position peaked at $3.33M in Q2 2019. 370 funds tracked by Wall St. Rank hold RGEN as of Q2 2020.

361 Capital held 6,152 shares of Repligen worth $760K as of Q2 2020.
361 Capital sold 955 Repligen shares in Q2 2020, an estimated $112K.
Repligen made up 0.36% of 361 Capital's portfolio in Q2 2020, its #130 holding.
361 Capital first reported a position in Repligen in Q1 2017 and has held it in 7 quarters since.
361 Capital's Repligen position peaked at $3.33M in Q2 2019.
370 funds tracked by Wall St. Rank held Repligen as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.